Clinical Phenogroups in Heart Failure With Preserved Ejection Fraction: Detailed Phenotypes, Prognosis, and Response to Spironolactone
Rationale and design of the GUIDE-IT study: Guiding Evidence Based Therapy Using Biomarker Intensified Treatment in Heart Failure
Heart Failure With Mid-Range (Borderline) Ejection Fraction: Clinical Implications and Future Directions
Heart Failure Outcomes With Volume-Guided Management
Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association
A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation in patients with systolic heart failure: rationale, design, and baseline patient characteristics
Noninvasive Imaging for the Evaluation of Diastolic Function: Promises Fulfilled
Empagliflozin, Health Status, and Quality of Life in Patients with Heart Failure and Preserved Ejection Fraction: The EMPEROR-Preserved Trial
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.